CIAS
EBS icon

CBIZ Investment Advisory Services’s Emergent Biosolutions EBS Stock Holding History

CBIZ Investment Advisory Services’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-100
Closed -$638 – 704
2025
Q2 		$638 Hold
100
– – ﹤0.01% 622
2025
Q1 		$486 Hold
100
– – ﹤0.01% 563
2024
Q4 		$956 Buy
+100
New +$918 ﹤0.01% 433

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
OHA
Oak Hill Advisors New York $878M AUM 106.46% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

CBIZ Investment Advisory Services's EBS Position: Q3 2025 in Review

CBIZ Investment Advisory Services sold out of Emergent Biosolutions (EBS) in Q3 2025, closing a stake of 100 shares — an estimated $638 sold.

CBIZ Investment Advisory Services first reported a position in EBS in Q4 2024 and held it in 3 quarters. The position peaked at $956 in Q4 2024. 169 funds tracked by Wall St. Rank hold EBS as of Q3 2025.

  • CBIZ Investment Advisory Services reported no remaining Emergent Biosolutions position as of Q3 2025 after selling out during the quarter.
  • CBIZ Investment Advisory Services sold 100 Emergent Biosolutions shares in Q3 2025, an estimated $638.
  • CBIZ Investment Advisory Services first reported a position in Emergent Biosolutions in Q4 2024 and held it in 3 quarters.
  • CBIZ Investment Advisory Services's Emergent Biosolutions position peaked at $956 in Q4 2024.
  • 169 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2025.

Based on CBIZ Investment Advisory Services's 13F filing for Q3 2025, filed 6 Nov 2025.